Willekens, C., Rahme, R., Duchmann, M., Vidal, V., Saada, V., Broutin, S., Delahousse, J., Renneville, A., Marceau, A., Clappier, E., Uzunov, M., Rossignol, J., Pascal, L., Simon, L., Micol, J. B., Pasquier, F., Raffoux, E., Preudhomme, C., Quivoron, C., Itzykson, R., Penard-Lacronique, V., Paci, A., Fenaux, P., Attar, E. C., Frattini, M., Braun, T., Ades, L., & De Botton, S. (2021). effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study. Leukemia & lymphoma, 62(2), 438–445. http://access.bl.uk/ark:/81055/vdc_100121847577.0x00003b